Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 132

1.

Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages.

Grent-'t-Jong T, Gross J, Goense J, Wibral M, Gajwani R, Gumley AI, Lawrie SM, Schwannauer M, Schultze-Lutter F, Navarro Schröder T, Koethe D, Leweke FM, Singer W, Uhlhaas PJ.

Elife. 2018 Sep 27;7. pii: e37799. doi: 10.7554/eLife.37799.

2.

Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention.

Leweke FM, Mueller JK, Lange B, Fritze S, Topor CE, Koethe D, Rohleder C.

CNS Drugs. 2018 Jul;32(7):605-619. doi: 10.1007/s40263-018-0539-z.

PMID:
30022465
3.

Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity.

Grimm O, Löffler M, Kamping S, Hartmann A, Rohleder C, Leweke M, Flor H.

Eur Neuropsychopharmacol. 2018 Jul;28(7):841-849. doi: 10.1016/j.euroneuro.2018.04.004. Epub 2018 Jun 7.

PMID:
29887287
4.

Neural correlates of binocular depth inversion illusion in antipsychotic-naïve first-episode schizophrenia patients.

Rohleder C, Koethe D, Fritze S, Topor CE, Leweke FM, Hirjak D.

Eur Arch Psychiatry Clin Neurosci. 2018 Mar 19. doi: 10.1007/s00406-018-0886-2. [Epub ahead of print]

PMID:
29556734
5.

Familial abnormalities of endocannabinoid signaling in schizophrenia.

Koethe D, Pahlisch F, Hellmich M, Rohleder C, Mueller JK, Meyer-Lindenberg A, Torrey EF, Piomelli D, Leweke FM.

World J Biol Psychiatry. 2018 Mar 22:1-9. doi: 10.1080/15622975.2018.1449966. [Epub ahead of print]

PMID:
29521179
6.

Virus discovery analyses on post-mortem brain tissue and cerebrospinal fluid of schizophrenia patients.

Tomasik J, Smits SL, Leweke FM, Eljasz P, Pas S, Kahn RS, Osterhaus ADME, Bahn S, de Witte LD.

Schizophr Res. 2018 Feb 22. pii: S0920-9964(18)30088-4. doi: 10.1016/j.schres.2018.02.012. [Epub ahead of print] No abstract available.

PMID:
29478863
7.

Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots.

Cooper JD, Ozcan S, Gardner RM, Rustogi N, Wicks S, van Rees GF, Leweke FM, Dalman C, Karlsson H, Bahn S.

Transl Psychiatry. 2017 Dec 18;7(12):1290. doi: 10.1038/s41398-017-0027-0.

8.

Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patients.

van Rees GF, Lago SG, Cox DA, Tomasik J, Rustogi N, Weigelt K, Ozcan S, Cooper J, Drexhage H, Leweke FM, Bahn S.

Brain Behav Immun. 2018 Jan;67:364-373. doi: 10.1016/j.bbi.2017.10.003. Epub 2017 Oct 4.

PMID:
28988033
9.

Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia.

Kannan G, Gressitt KL, Yang S, Stallings CR, Katsafanas E, Schweinfurth LA, Savage CLG, Adamos MB, Sweeney KM, Origoni AE, Khushalani S, Bahn S, Leweke FM, Dickerson FB, Yolken RH, Pletnikov MV, Severance EG.

Transl Psychiatry. 2017 Aug 1;7(8):e1186. doi: 10.1038/tp.2017.162.

10.

Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study.

Kranaster L, Hoyer C, Aksay SS, Bumb JM, Leweke FM, Janke C, Thiel M, Lutz B, Bindila L, Sartorius A.

Eur Arch Psychiatry Clin Neurosci. 2017 Dec;267(8):781-786. doi: 10.1007/s00406-017-0789-7. Epub 2017 Mar 24.

PMID:
28342110
11.

How gender affects the pharmacotherapeutic approach to treating psychosis - a systematic review.

Lange B, Mueller JK, Leweke FM, Bumb JM.

Expert Opin Pharmacother. 2017 Mar;18(4):351-362. doi: 10.1080/14656566.2017.1288722. Epub 2017 Feb 13. Review.

PMID:
28129701
12.

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJ, Birnbaum ML, Bloomfield MA, Bressan RA, Buchanan RW, Carpenter WT, Castle DJ, Citrome L, Daskalakis ZJ, Davidson M, Drake RJ, Dursun S, Ebdrup BH, Elkis H, Falkai P, Fleischacker WW, Gadelha A, Gaughran F, Glenthøj BY, Graff-Guerrero A, Hallak JE, Honer WG, Kennedy J, Kinon BJ, Lawrie SM, Lee J, Leweke FM, MacCabe JH, McNabb CB, Meltzer H, Möller HJ, Nakajima S, Pantelis C, Reis Marques T, Remington G, Rossell SL, Russell BR, Siu CO, Suzuki T, Sommer IE, Taylor D, Thomas N, Üçok A, Umbricht D, Walters JT, Kane J, Correll CU.

Am J Psychiatry. 2017 Mar 1;174(3):216-229. doi: 10.1176/appi.ajp.2016.16050503. Epub 2016 Dec 6. Review.

PMID:
27919182
13.

Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical features.

Coughlin JM, Hayes LN, Tanaka T, Xiao M, Yolken RH, Worley P, Leweke FM, Sawa A.

Schizophr Res. 2017 May;183:64-69. doi: 10.1016/j.schres.2016.10.040. Epub 2016 Nov 23.

PMID:
27889384
14.

Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence.

Rohleder C, Müller JK, Lange B, Leweke FM.

Front Pharmacol. 2016 Nov 8;7:422. eCollection 2016. Review.

15.

What is the promise of nicotinergic compounds in schizophrenia treatment?

Mueller JK, Rohleder C, Leweke FM.

Future Med Chem. 2016 Nov;8(17):2009-2012. doi: 10.4155/fmc-2016-0154. Epub 2016 Oct 14. No abstract available.

PMID:
27739330
16.

Association of anandamide with altered binocular depth inversion illusion in schizophrenia.

Reuter AR, Bumb JM, Mueller JK, Rohleder C, Pahlisch F, Hanke F, Arens E, Leweke FM, Koethe D, Schwarz E.

World J Biol Psychiatry. 2017 Sep;18(6):483-488. doi: 10.1080/15622975.2016.1246750. Epub 2016 Nov 11.

PMID:
27734750
17.

The association of pineal gland volume and body mass in obese and normal weight individuals: a pilot study.

Grosshans M, Vollmert C, Vollstaedt-Klein S, Nolte I, Schwarz E, Wagner X, Leweke M, Mutschler J, Kiefer F, Bumb JM.

Psychiatr Danub. 2016 Sep;28(3):220-224.

18.

[In process].

Müller JK, Leweke FM.

Med Monatsschr Pharm. 2016 Sep;39(9):377-84. Review. German. No abstract available.

PMID:
29956512
19.

Bipolar disorder: clinical overview.

Müller JK, Leweke FM.

Med Monatsschr Pharm. 2016 Sep;39(9):363- 9. Review. English, German.

PMID:
29956510
20.

[In process].

Leweke FM, Müller WE.

Med Monatsschr Pharm. 2016 Sep;39(9):359. German. No abstract available.

PMID:
29956509

Supplemental Content

Loading ...
Support Center